Cell Death Activator CIDE-A (CIDEA) Antibody

Este producto es parte de CIDEA - Cell death inducing DFFA like effector A
Product Graph
637€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cell Death Activator CIDE-A (CIDEA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx412478
tested applications
WB, IHC

Description

Cell Death Activator CIDE-A (CIDEA) Antibody is a Rabbit Polyclonal antibody against Cell Death Activator CIDE-A (CIDEA).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Cell Death Activator CIDE-A (CIDEA)
Host
Rabbit
Reactivity
Mouse
Recommended Dilution
Validated in IHC-P. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified
Size 1
100 µg
Form
Liquid
Tested Applications
WB, IHC
Buffer
PBS. Contains sodium azide.
Availability
Shipped within 3-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O70302
Alias
CIDE-A, cell death-inducing DFFA-like effector a, cell death inducing DFFA like effector a,CIDEA
Background
Antibody anti-CIDEA
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

CIDEA is a lipid droplet-associated protein involved in regulating lipid metabolism and energy homeostasis. It promotes lipid droplet fusion and inhibits lipolysis by modulating the activity of key enzymes such as adipose triglyceride lipase (ATGL). CIDEA is highly expressed in brown adipose tissue, where it contributes to thermogenesis and energy expenditure. Beyond its metabolic functions, CIDEA also plays a role in apoptosis, where it interacts with caspase-activated DNAse to mediate DNA fragmentation. Dysregulation of CIDEA is associated with obesity, insulin resistance, and non-alcoholic fatty liver disease. Research on CIDEA focuses on its dual roles in lipid metabolism and apoptosis, offering potential therapeutic targets for metabolic disorders and cancer.

Related Products

FNab01710

anti- CIDEA antibody

Acts as a CEBPB coactivator in mammary epithelial cells to control the expression of a subset of CEBPB downstream target genes, including ID2, IGF1, PRLR, SOCS1, SOCS3, XDH, but not casein. By interacting with CEBPB, strengthens the association of CEBPB with the XDH promoter, increases histone acetylation and dissociates HDAC1 from the promoter(By similarity). Binds to lipid droplets and regulates their enlargement, thereby restricting lipolysis and favoring storage. At focal contact sites between lipid droplets, promotes directional net neutral lipid transfer from the smaller to larger lipid droplets. The transfer direction may be driven by the internal pressure difference between the contacting lipid droplet pair and occurs at a lower rate than that promoted by CIDEC. When overexpressed, induces apoptosis. The physiological significance of its role in apoptosis is unclear.

Ver Producto
P8303

Recombinant Human CIDEA

Ver Producto
abx006244

Cell Death Activator CIDE-A (CIDEA) Antibody

CIDEA Antibody is a Rabbit Polyclonal Antibody against CIDEA.

Ver Producto